Reversal Strategies for Intracranial Hemorrhage Related to Direct Oral Anticoagulant Medications
Direct oral anticoagulants (DOACs) are a new class of anticoagulants that directly inhibit either thrombin or factor Xa in the coagulation cascade. They are being increasingly used instead of warfarin or other vitamin K antagonists (VKAs). Adverse side effects of DOACs may result in hemorrhagic comp...
Saved in:
| Main Authors: | Alok Dabi, Aristides P. Koutrouvelis |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Critical Care Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2018/4907164 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage
by: A. S. Gerasimenko, et al.
Published: (2021-05-01) -
Direct oral anticoagulation versus no therapy or antiplatelet for stroke prevention in patients with atrial fibrillation and history of intracranial hemorrhage: a systematic review and meta-analysis
by: Denis Sablot, et al.
Published: (2025-04-01) -
New oral anticoagulants and their reversal agents
by: Crista L. Laslo, et al.
Published: (2018-10-01) -
DIRECT ORAL ANTICOAGULANTS
by: I. Tzoran, et al.
Published: (2016-06-01) -
Oral Anticoagulant Therapy in Patients with Atrial Fibrillation After Intracranial Hemorrhage: A Meta-Analysis of Randomized Controlled Trials
by: Guangjing Zhang BM, et al.
Published: (2025-08-01)